I joined D Young & Co in 2016 with a background in molecular biology, genetics and neuroscience. I thoroughly enjoy supporting our innovative clients through utilising my scientific and legal knowledge.
I have experience in drafting, prosecution, opposition, appeal and freedom-to-operate work in a broad range of life science areas. I am particularly experienced in the technical fields of genetics, vaccines, peptides and food technology.
Prior to joining D Young & Co I completed my PhD, followed by working as a post-doctoral researcher for four years at the Cambridge Institute for Medical Research. My research focused on generating and characterising in vivo models of neurodegenerative diseases and the cellular process autophagy.
- BA (Hons) Biological Sciences, St Peter's College, University of Oxford.
- PhD in Neurology / Functional Genetics, University College London and Medical Research Council Harwell.
- Certificate in Intellectual Property Law, Queen Mary, University of London.
- Student member of the Chartered Institute of Patent Attorneys (CIPA).
- Student member of the European Patent Institute (EPI).
- Siddiqi, FH. et al. Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing. Nature Communications. 2019; 10(1817):1-14.
- Ricketts, T*. et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO. 2018; 37(e98684):1-15.
- Ashkenazi, A. et al. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature. 2017; 545(7652):108-111.
- Ricketts, T*. et al. A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects. PLOS ONE. 2014; 9(1):1-14.